Disclaimer/Disclosure Ology Bio does not warrant that the information contained in this Website or Blog is accurate, complete, current, or useful. The information in this Website and Blog is provided without any express or implied warranties, including but not limited to warranties of merchantability, fitness for a particular purpose or noninfringement. The [...]
Cookie Policy Cookie policy with link to Privacy policy Ology Bioservices uses cookies to analyze website traffic to improve website functionality and provide you with a better browsing experience. Information about the use of cookies on this site and how you can decline them is provided in our privacy policy. By using [...]
A Retrospective Introduction Ology Bioservices is a trusted biopharmaceutical partner, providing high quality products and services for over 15 years, on-time and on-budget. Ology Bioservices, Inc. (Ology Bio) is a privately owned, US-based, mid-sized, Commercial Development and Manufacturing Organization (CDMO) providing services from sequence to Phase II, to both government and commercial [...]
Tomic MT, Espinoza Y, Martinez Z, et al. Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model. Toxins 2019, 11(4), 208; https://doi.org/10.3390/toxins11040208. Read More >
Ology Bioservices Wins Two Department of Defense Awards Totaling More Than $135 Million ALACHUA, Fla.--(BUSINESS WIRE)--Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through its Platforms for Rapid Integrated Solutions for Medical Countermeasures (PRISM) office, has awarded the company with two [...]
Ology Bioservices Appoints Vaccines and Biologics Manufacturing Industry Veteran, Brandon Brega, as Chief Operating Officer ALACHUA, Fla.--(BUSINESS WIRE)--Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today the appointment of vaccines and biologics manufacturing industry expert, Brandon Brega, to the position of Chief Operating Officer, effective immediately. In this [...]
Ology Bioservices to Present at the 30thAnnual Piper Jaffray Healthcare Conference ALACHUA, Fla., November 20, 2018 - - Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that management will present at the 30thAnnual Piper Jaffray Healthcare conference, to be held at the Lotte New York Palace hotel, [...]
Ology Bioservices Strengthens Management Team with Addition of Timothy Cooke, Ph.D. as Senior Vice President of Commercial Business ALACHUA, Fla.--(BUSINESS WIRE)--Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that industry veteran Timothy Cooke, Ph.D., has joined the Company as Senior Vice President of Commercial Business. “Tim brings [...]
Ology Bioservices Wins $8.4 Million Defense Department Award to Produce Anti-Ebola Medical Countermeasure ALACHUA, Fla.--(BUSINESS WIRE)--Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that it was awarded an Other Transaction Agreement (OTA) to support the Joint Project Manager Medical Countermeasure Systems (JPM-MCS), a component of the Joint [...]
Barrett PN, Terpening SJ, Snow D, Cobb RR, Kistner O. Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases. Expert Review of Vaccines. 2017;16(9):883-894. Read More >
COVID-19 Letter